左心房容积指数对单纯外科主动脉瓣置换术的风险预测:多中心主动脉瓣置换注册研究结果
本研究基于8家中心2016至2021年间812例因主动脉瓣狭窄行单纯外科主动脉瓣置换术的患者,纳入其中366例有术前左心房容积指数(LAVI)数据者,以40 mL/m2为界分为左房扩大组(n=219)与非扩大组(n=147),比较5年结局。结果显示左房扩大组心脏死亡率更高(13.4% vs 2.6%,P=.001),术前LAVI≥40 mL/m2是心脏死亡率的独立预测因子(校正HR 2.08,95%CI 1.01-4.82,P=.041),并与全因死亡和心衰再入院相关。
要点
- 术前LAVI≥40 mL/m2是单纯SAVR术后心脏死亡的独立预测因子(校正HR 2.08)。
- 左房扩大组5年心脏死亡率13.4%,显著高于非扩大组的2.6%(P=.001)。
- 左房扩大还与全因死亡(17.4% vs 7.6%)和心衰再入院(11.0% vs 2.8%)升高相关。
核心结论
- 在重度主动脉瓣狭窄行单纯SAVR的患者中,术前LAVI≥40 mL/m2与中期死亡和心衰相关,提示在显著左房扩大前实施SAVR可能改善预后。
研究设计与样本
- 多中心注册研究,纳入8家机构2016至2021年间812例因主动脉瓣狭窄行单纯SAVR患者中的366例有术前LAVI数据者。
- 以ROC曲线分析得出的最佳值40 mL/m2为界,将患者分为左房扩大组(n=219)与非扩大组(n=147),比较5年结局。
主要发现
- 左房扩大组与非扩大组年龄(76.0 vs 76.0岁,P=.489)和性别(男性44.3% vs 50.3%,P=.256)可比。
- 左房扩大组eGFR较低(52.3 vs 59.2 mL/min/1.73 m2,P=.002)、血清白蛋白较低(3.9 vs 4.0 g/dL,P=.003)、射血分数较低(65.0% vs 70.0%,P<.001)。
- 左房扩大组心房颤动有更高趋势(20.1% vs 12.2%,P=.066),STS-PROM较高(3.10% vs 2.91%,P=.029)。
- 左房扩大组5年心脏死亡率更高(13.4% vs 2.6%,P=.001)。
- 多因素分析显示术前LAVI≥40 mL/m2是心脏死亡的独立预测因子(校正HR 2.08,95%CI 1.01-4.82,P=.041),并与全因死亡(17.4% vs 7.6%,P=.002)和心衰再入院(11.0% vs 2.8%,P=.013)相关。
关键数值与推荐
- LAVI最佳界值为40 mL/m2,由ROC曲线分析得出,用于分组。
- 术前LAVI≥40 mL/m2为心脏死亡的独立预测因子,校正HR 2.08(95%CI 1.01-4.82,P=.041)。
临床怎么用
- 对重度主动脉瓣狭窄拟行单纯SAVR患者,术前应评估LAVI,LAVI≥40 mL/m2提示中期死亡和心衰风险较高。
- 考虑在显著左房扩大发生前实施SAVR,以可能改善预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Aortic stenosis (AS) induces left ventricular diastolic dysfunction, which is associated with left atrial (LA) dysfunction. However, the prognostic impact of LA dysfunction in the surgical intervention for AS remains unclear. METHODS: Among the 812 patients who underwent isolated surgical aortic valve replacement (SAVR) for AS at 8 institutions between 2016 and 2021, 366 with available preoperative left atrial volume index (LAVI) were included. Based on the optimal value of 40 mL/m2-derived from receiver operating characteristic curve analyses-patients were stratified into a LA enlargement group (n = 219) and a non-enlargement group (n = 147), and 5-year outcomes were investigated. RESULTS: Age (76.0 vs 76.0 years, P = .489) and sex (male 44.3% vs 50.3%, P = .256) were comparable, while the LA enlargement group showed lower estimated glomerular filtration rate (eGFR) (52.3 vs 59.2 mL/min/1.73 m2, P = .002), serum albumin (3.9 vs 4.0 g/dL, P = .003), and ejection fraction (65.0% vs 70.0%, P < .001), as well as a higher tendency for atrial fibrillation (20.1% vs 12.2%, P = .066), and higher Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) (3.10% vs 2.91%, P = .029). The 5-year incidence of cardiac mortality was higher in the LA enlargement group (13.4% vs 2.6%, P = .001). Multivariable analysis identified preoperative LA enlargement (LAVI ≥ 40 mL/m2) as an independent predictor of cardiac mortality (adjusted hazard ratio [HR], 2.08; 95% confidence interval [CI], 1.01-4.82; P = .041). Left atrial enlargement was also associated with higher all-cause mortality and heart failure readmission (17.4% vs 7.6%, P = .002; and 11.0% vs 2.8%, P = .013, respectively). CONCLUSIONS: In patients with severe AS undergoing isolated SAVR, a preoperative LAVI ≥ 40 mL/m2 was associated with midterm mortality and heart failure, suggesting that SAVR before significant LA enlargement may improve prognosis.
引用
- Handa K, Maeda K, Pak K, et al. Left Atrial Volume Index as a Risk Predictor in Isolated Surgical Aortic Valve Replacement: Results from the Multicentre Aortic Valve Replacement Registry. Eur J Cardiothorac Surg. 2026. PMID: 41525340. doi:10.1093/ejcts/ezag022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。